Laboratory versus daily life gait characteristics in patients with multiple sclerosis, Parkinson's disease, and matched controls.

Vrutangkumar V Shah James McNames Martina Mancini Patricia Carlson-Kuhta Rebbeca Irene Spain John G Nutt Mahmoud El-Gohary Carolin Curtze Fay B Horak

Published in: Journal of neuroengineering and rehabilitation (2020)

Larger AUC for daily life gait measures compared to the laboratory gait measures suggest that daily life monitoring may be more sensitive to impairments from neurological disease, but each neurological disease may require different gait outcome measures.

Keyphrases

cerebral palsy
physical activity